Loading...
Neoadjuvant checkpoint blockade for cancer immunotherapy
Cancer immunotherapies that target the programmed cell death 1 (PD-1):programmed death-ligand1 (PD-L1) immune checkpoint pathway have ushered in the modern oncology era. Drugs that block PD-1 or PD-L1 facilitate endogenous antitumor immunity and, because of their broad activity spectrum, have been r...
Na minha lista:
| Udgivet i: | Science |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789854/ https://ncbi.nlm.nih.gov/pubmed/32001626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aax0182 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|